Serum Endoglin and IL-6 Levels as Complementary Diagnostic Biomarkers for Hepatocellular Carcinoma in Egyptian Liver Cirrhosis Patients
Research Journal of Immunology · 2016
DOI: 10.3923/rji.2017.1.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Research Journal of Immunology, 2016. Verfasst von M. A. Abdelwa und 3 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Abdelwa, M. A., Elbedew, M. M., Amin, A. M., & Tawfik, A. K. (2016). Serum Endoglin and IL-6 Levels as Complementary Diagnostic Biomarkers for Hepatocellular Carcinoma in Egyptian Liver Cirrhosis Patients. Research Journal of Immunology. https://doi.org/10.3923/rji.2017.1.7
Vancouver
Abdelwa MA, Elbedew MM, Amin AM, Tawfik AK. Serum Endoglin and IL-6 Levels as Complementary Diagnostic Biomarkers for Hepatocellular Carcinoma in Egyptian Liver Cirrhosis Patients. Research Journal of Immunology. 2016. doi:10.3923/rji.2017.1.7
BibTeX
@article{Abdelwa2016,
author = {Abdelwa, M. A. and Elbedew, M. M. and Amin, A. M. and Tawfik, A. K.},
title = {Serum Endoglin and IL-6 Levels as Complementary Diagnostic Biomarkers for Hepatocellular Carcinoma in Egyptian Liver Cirrhosis Patients},
journal = {Research Journal of Immunology},
year = {2016},
doi = {10.3923/rji.2017.1.7}
}
EUVIMED